Morepen Laboratories’ arm gets nod to form new subsidiary company

19 Feb 2025 Evaluate

Morepen Laboratories’ wholly owned subsidiary-- Dr. Morepen (DML) has received approval from Board of Directors for the formation of a new subsidiary company on February 19, 2025. The proposed entity will be named ‘Quick Med’ or any other name as approved by the Central Registration Centre, Ministry of Corporate Affairs (Proposed Company). 

Upon incorporation, the proposed company will become a step-down subsidiary of Morepen Laboratories. The proposed new company will operate in the pharmaceutical sector, specializing in the 'Online Retail Pharmacy' business.  

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. 


Morepen Laboratories Share Price

34.63 -0.95 (-2.67%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×